Islet autoimmunity status in Asians with young-onset diabetes (12-40 years): Association with clinical characteristics, beta cell function and cardio-metabolic risk factors

Diabetes Research and Clinical Practice

Volumn 80, Issue 2, 2008, Pages 224-230

  Thai, A C ^a   Mohan, V ^b   Khalid, B A K ^c   Cockram, C S ^d   Pan, C Y ^e   Zimmet, P ^f   Yeo, J P ^g   Xing, Zhu Xi ^h   Li, Shi Hong ^h   Juming, Lu ^e   Wan Mohamud, Wan Nazaimoon ⁱ   Ismail, Ikram Shah ^j   Nadior, Noraini ^k   Letchuman, G R ^l   Singaraveloo, S ^m   Wan Bebakar, Wan Mohamad ⁿ   Mohan, Rema ^b   Cheow, Soon Puay ^o   Chuan, Loh Keh ^o   Horn, Lee Choon ^p   Subramaniam, Tavintharan ^p   Bee, Chionh Siok ^q   more..

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

^c DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^d Chinese University of Hong Kong   (Hong Kong)

^e CHINESE PLA GENERAL HOSPITAL   (China)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^g Novo Nordisk Pharma Singapore Pte Ltd   (Singapore)

^h FUDAN UNIVERSITY   (China)

ⁱ INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^j UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^k Damansara Specialist Hospital   (Malaysia)

^l HOSPITAL RAJA PERMAISURI BAINUN   (Malaysia)

^m Faculty of Chemical and Natural Resources Engineering   (Malaysia)

ⁿ HOSPITAL UNIVERSITI SAINS MALAYSIA   (Malaysia)

^o TAN TOCK SENG HOSPITAL   (Singapore)

^p CHANGI GENERAL HOSPITAL   (Singapore)

^q NATIONAL UNIVERSITY HOSPITAL   (Singapore)

more..

Author keywords

Beta cell function; GADA; IA 2A; Metabolic syndrome; Young Asians

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ALBUMINURIA; ARTICLE; ASIAN; AUTOIMMUNITY; CARDIOVASCULAR SYMPTOM; CELL FUNCTION; CHINA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALAYSIA; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET CELL; RISK FACTOR; SCHOOL CHILD; SINGAPORE;

EID: 41749108905     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.12.003     Document Type: Article

References (43)

1. Onkamo P., Väänänen S., Karvonen M., and Tuomilehto J. Worldwide increase in incidence of type 1 diabetes-the analysis of the data on published incidence trends. Diabetologia 42 (1999) 1395-1403
2. Karvonen M., Tuomilehto J., Libman I., LaPorte R., and World Health Organization DIAMOND Project Group. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependant) diabetes mellitus. Diabetologia 36 (1993) 883-892
3. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
4. Kitagawa T., Owada M., Urakami T., and Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus in Japanese school children correlates with an increased intake of animal protein and fat. Clin. Pediatr. 37 (1998) 111-115
5. Likitmaskul S., Kiattisathavee P., Chaichanwatanakul K., Punnakanta L., Angsusingha K., and Tuchinda C. Increasing prevalence of type 2 diabetes mellitus in Thai children and adolescents associated with increasing prevalence of obesity. J. Pediatr. Endocrinol. Metab. 16 (2003) 71-77
6. Urakami T., Kubota S., Nitadori Y., Harada K., Owada M., and Kitagawa T. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28 (2005) 1876-1881
7. Ramachandran A., Snehalatha C., Satyavani K., Sivasankari S., and Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care 26 (2003) 1022-1025
8. Otani T., Yokoyama H., Higami Y., Kasahara T., Uchigata Y., and Hirata Y. Age of onset and type of Japanese younger diabetics in Tokyo. Diabetes Res. Clin. Pract. 10 (1990) 241-244
9. Cockram C.S. Diabetes mellitus: perspective from the Asia-Pacific region. Diabetes Res. Clin. Pract. 50 Suppl. 2 (2000) S3-S7
10. Arnqvist H.J., Littorin B., Nyström L., Schersten B., Ostman J., Blohme J., et al. Difficulty in classifying diabetes at presentation in the young adult. Diabet. Med. 10 (1993) 606-613
11. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 23 (2000) 381-389
12. Fagot-Campagna A., Pettitt D.J., Engelgau M.M., Burrows N.R., Geiss L.S., Valdez R., et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J. Pediatr. 136 (2000) 664-672
13. Ferrara A., Imperatore G., Quesenberry C.P., Karter A.J., Fagot-Campagna A., Ergas I.J., et al. Characteristics and quality of health care of type 1 and type 2 diabetic youths: the Northern California Kaiser Performance Diabetes Registry. Diabetes 51 Suppl. 2 (2002) A26
14. Barrett T.G., Ehtisham S., Smith A., and Hattersley A.T. UK Diabetes survey shows type 2 diabetes present in 0.4% of newly diagnosed children, associated with overweight, female, and ethnic minority status. Diabetes 51 Suppl. 2 (2002) A25
15. In: Ganz M. (Ed). Prevention of Type 2 Diabetes (2005), Wiley, New York, NY 21-40
16. Borg H., Arnqvist H.J., Björk E., Bolinder J., Eriksson J.W., Nyström L., et al. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 years) in the Diabetes Incidence Study in Sweden (DISS). Diabetologia 46 (2003) 173-181
17. Yokoyama H., Okudaira M., Otani T., Sato A., Miura J., Takaike H., et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int. 58 (2000) 302-311
18. Yokoyama H., Okudaira M., Otani T., Watanabe C., Takaike H., Miuira J., et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients: risk analysis. Diabetes Care 21 (1998) 1080-1085
19. Verge C.F., Howard N.J., Rowley M.J., Mackay I.R., Zimmet P.Z., Egan M., et al., A population-based study. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM. Diabetologia 37 (1994) 1113-1120
20. Zimmet P.Z., Rowley M.J., Mackay I.R., Knowles W.J., Chen Q.Y., Chapman L.H., et al. The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels of insulin-dependent diabetes mellitus in Europid and Asian subjects. J. Diabetes Complications 7 (1993) 1-7
21. Wan Nazaimoon W.M., Faridah I., Singaraveloo M., Ismail I.S., Wan Mohamad W.B., Letchuman R., et al. Prevalence of glutamic acid decarboxylase antibodies amongst young Malaysian diabetics. Diabetes Res. Clin. Pract. 43 (1999) 59-66
22. Pan C.Y., So W.Y., Khalid B.A.K., Mohan V., Thai A.C., Zimmet P., et al. Metabolic, immunological and clinical characteristics in newly diagnosed Asian diabetes patients aged 12-40 years. Diabet Med. 21 (2004) 1007-1013
23. Chen Q.Y., Rowley M.J., Byrne G.C., Jones T.W., Tuomi T., Knowles W.J., et al. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives. Pediatr. Res. 34 (1993) 785-790
24. Law R.H., Rowley M.J., Mackay I.R., and Corner B. Expression in Saccharomyces cerevisiae of antigenically and enzymatically active recombinant glutamic acid decarboxylase. J. Biotechnol. 61 (1998) 57-68
25. Verge C.F., Stenger D., Bonifacio E., Colman P.G., Pilcher C., Bingley P.J., et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop. Diabetes 47 (1998) 1857-1866
26. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
27. National Cholesterol Education Program, Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), NIH Publication No. 02-5215, National Heart, Lung, and Blood Institute, Bethesda, MD, 2002, pp. 3144-3421.
28. The Asia-Pacific perspective: redefining obesity and its treatment, Regional office for the Western Pacific of the World Health Organization, World Health Organization, International Association for the Study of Obesity and International Obesity Task Force, Health Communications Australia Pty Limited, Sydney, 2000, pp. 17-21.
29. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 (2006) S4-S42
30. Dabelea D., D'Agostino Jr. R.B., Mayer-Davis E.J., Pettitt D.J., Imperatore G., Dolan L.M., et al. Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care 29 (2006) 290-294
31. Rodriguez B.L., Fujimoto W.Y., Mayer-Davis E.J., Imperatore G., Williams D.E., Bell R.A., et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care 29 (2006) 1891-1896
32. Ng M.C., Lee S.C., Ko G.T., Li J.K., So W.Y., Hashim Y., et al. Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. Diabetes Care 24 (2001) 663-671
33. Mohan V., Deepa R., Bhatia E., Singh A.K., Hitman G.A., Zimmet P.Z., et al. Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes. Diabet. Med. 15 (1998) 156-159
34. Li J.K., Chan J.C., Zimmet P.Z., Rowley M.J., Mackay I.R., and Cockram C.S. Young Chinese adults with new onset of diabetic ketoacidosis-clinical course, autoimmune status and progression of pancreatic beta-cell function. Diabet. Med. 17 (2000) 295-298
35. Landin-Olsson M., Karlsson A., Dahlquist G., Blom L., Lernmark A., and Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32 (1989) 387-395
36. Park Y. Why is type 1 diabetes uncommon in Asia?. Ann. N.Y. Acad. Sci. 1079 (2006) 31-40
37. Kockum I., Lernmark A., Dahlquist G., Falorni A., Hagopian W.A., Landin-Olsson M., et al., The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group. Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. Horm. Metab. Res. 28 (1996) 344-347
38. Thai A.C., Ng W.Y., Loke K.Y., Lee W.R., Lui K.F., and Cheah J.S. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia 40 (1997) 1425-1430
39. In: Kiess W., Marcus C., and Wabitsch M. (Eds). Obesity in Childhood and Adolescence vol. 9 (2004), Pediatr. Adolesc. Med., Basel, Karger pp 170-180
40. Eppens M.C., Craig M.E., Jones T.W., Silink M., Ong S., Yeo J.P., and on behalf of the International Diabetes Federation Western Pacific Region Steering Committee. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr. Med. Res. Opin. 22 (2006) 1013-1020
41. Wu Y. Overweight and obesity in China. BMJ 333 (2006) 362-363
42. Matsushita Y., Yoshiike N., Kaneda F., Yoshita K., and Takimoto H. Trends in childhood obesity in Japan over the last 25 years from the national nutrition survey. Obes. Res. 12 (2004) 205-214
43. Yoon K.H., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368 (2006) 1681-1688